EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned

Roy M Gulick, Alice K Pau, Eric Daar, Laura Evans, Rajesh T Gandhi, Pablo Tebas, Renée Ridzon iD, Henry Masur, H Clifford Lane, NIH COVID-19 Treatment Guidelines Panel, Adaora A Adimora, Jason Baker und 48 weitere

Annals of Internal Medicine · 2024-11 · 177 (11) · 1547-1557

DOI: 10.7326/annals-24-00464 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Annals of Internal Medicine, 2024-11. Verfasst von Roy M Gulick und 59 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine, New York, New York (R.M.G.). Hauptthemen laut MEDLINE: COVID-19, National Institutes of Health (U.S.), SARS-CoV-2, Practice Guidelines as Topic. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DESCRIPTION: In March 2020, the White House Coronavirus Task Force determined that clinicians in the United States needed expert treatment guidelines to optimally manage patients with COVID-19, a potentially life-threatening disease caused by a new pathogen for which no specific treatments were known to be effective. METHODS: The U.S. Department of Health and Human Services requested that the National Institutes of Health (NIH) take the lead in expeditiously convening a panel of experts to create "living" guidelines that would be widely accessible and capable of frequent updating as important new information became available. RECOMMENDATIONS: The purpose of this article is to expand on the experiences of the NIH COVID-19 Treatment Guidelines Panel (the Panel) over the past 4 years, summarize the Panel's final recommendations for COVID-19, highlight some challenges and unanswered questions about COVID-19 management, and inform future responses to public health emergencies. The Panel was formed in March 2020, and the first iteration of the guidelines was released in April 2020. Now that the public health emergency has ended, the NIH COVID-19 Treatment Guidelines have sunsetted. This role will now fall to professional societies and organizations, such as the American College of Physicians, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the World Health Organization, all of which have been active in this area.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19National Institutes of Health (U.S.)SARS-CoV-2Practice Guidelines as TopicHumansUnited StatesCOVID-19 Drug TreatmentAntiviral Agents

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Weill Cornell Medicine, New York, New York (R.M.G.).
  • National Institutes of Health, Bethesda, Maryland (A.K.P., R.R., H.M., H.C.L.).
  • Harbor-UCLA Medical Center, Torrance, California (E.D.).
  • University of Washington, Seattle, Washington (L.E.).
  • Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (R.T.G.).
  • University of Pennsylvania, Philadelphia, Pennsylvania (P.T.).

ORCID-Profile: Renée Ridzon

Förderung

  • NIH HHS
  • Intramural CDC HHS

Zitieren

APA

Gulick, R. M., Pau, A. K., Daar, E., Evans, L., Gandhi, R. T., Tebas, P., Ridzon, R., Masur, H., Lane, H. C., NIH COVID-19 Treatment Guidelines Panel, Adimora, A. A., Baker, J., Kreuziger, L. B., Bedimo, R., Belperio, P., Bhalla, A., Burgess, T., Campbell, D., Cantrill, S., …, & Swindells, S. (2024). National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. Annals of Internal Medicine, 177(11), 1547-1557. https://doi.org/10.7326/annals-24-00464

Vancouver

Gulick RM, Pau AK, Daar E, Evans L, Gandhi RT, Tebas P, et al. National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned. Annals of Internal Medicine. 2024;177(11):1547-1557. doi:10.7326/annals-24-00464

BibTeX
@article{Gulick2024,
  author = {Gulick, Roy M and Pau, Alice K and Daar, Eric and Evans, Laura and Gandhi, Rajesh T and Tebas, Pablo and Ridzon, Renée and Masur, Henry and Lane, H Clifford and NIH COVID-19 Treatment Guidelines Panel, NIH COVID-19 Treatment Guidelines Panel and Adimora, Adaora A and Baker, Jason and Kreuziger, Lisa Baumann and Bedimo, Roger and Belperio, Pamela and Bhalla, Anoopindar and Burgess, Timothy and Campbell, Danielle and Cantrill, Stephen and Chew, Kara and Chiotos, Kathleen and Coopersmith, Craig and Davey, Richard and Dzierba, Amy and Eisnor, Derek and Eschenauer, Gregory and Francis, Joseph and Gallagher, John and Glidden, David and Goldenberg, Neil and Grund, Birgit and Han, Alison and Hardy, Erica and Harrison, Carly and Henderson, Lauren and Higgs, Elizabeth and Hinkson, Carl and Hughes, Brenna and Johnson, Steven and Keller, Marla and Kim, Arthur and Knight, Richard and Kuriakose, Safia and Lennox, Jeffrey and Lerner, Andrea and Levy, Mitchell and Li, Jonathan and MacBrayne, Christine and Martin, Greg and Nadig, Nandita and Nason, Martha and Patel, Pragna and Pavia, Andrew and Proschan, Michael and Schulert, Grant and Seam, Nitin and Sheikh, Virginia and Simpson, Steven and Singh, Kanal and Swindells, Susan},
  title = {National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned},
  journal = {Annals of Internal Medicine},
  year = {2024},
  volume = {177},
  number = {11},
  pages = {1547--1557},
  doi = {10.7326/annals-24-00464}
}
Kostenlos starten →